PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: vincenzopio.dinoia@ifo.it.\', \'Microbiology and Virology Unit, Dermatological Clinical Department, IRCCS San Gallicano Dermatological Institute, Italy.\', \'Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Italy.\', \'Otolaryngology Head and Neck Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Biostatistic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0959-8049(22)00032-610.1016/j.ejca.2022.01.011
?:doi
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 35245863
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all